Society of Interventional Radiology Multidisciplinary Position Statement on Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease to the Lungs

To state the Society of Interventional Radiology's position on the use of image-guided thermal ablation for the treatment of early stage non-small cell lung cancer, recurrent lung cancer, and metastatic disease to the lung. A multidisciplinary writing group, with expertise in treating lung canc...

Full description

Saved in:
Bibliographic Details
Published inJournal of vascular and interventional radiology Vol. 32; no. 8; pp. 1241.e1 - 1241.e12
Main Authors Genshaft, Scott J., Suh, Robert D., Abtin, Fereidoun, Baerlocher, Mark O., Chang, Albert J., Dariushnia, Sean R., Devane, A. Michael, Faintuch, Salomao, Himes, Elizabeth A., Lisberg, Aaron, Padia, Siddharth, Patel, Sheena, Tam, Alda L., Yanagawa, Jane
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.08.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To state the Society of Interventional Radiology's position on the use of image-guided thermal ablation for the treatment of early stage non-small cell lung cancer, recurrent lung cancer, and metastatic disease to the lung. A multidisciplinary writing group, with expertise in treating lung cancer, conducted a comprehensive literature search to identify studies on the topic of interest. Recommendations were drafted and graded according to the updated SIR evidence grading system. A modified Delphi technique was used to achieve consensus agreement on the recommendation statements. A total of 63 studies, including existing systematic reviews and meta-analysis, retrospective cohort studies, and single-arm trials were identified. The expert writing group developed and agreed on 7 recommendations on the use of image-guided thermal ablation in the lung. SIR considers image-guided thermal ablation to be an acceptable treatment option for patients with inoperable Stage I NSCLC, those with recurrent NSCLC, as well as patients with metastatic lung disease.
ISSN:1051-0443
1535-7732
DOI:10.1016/j.jvir.2021.04.024